• Test Code:
    9502
  • Department:
  • Test Synonyms:
    Mucopolysaccharides, Quantitative Mucopolysaccharides, Electrophoresis
  • CPT Code(s):
    82664 83864 82540
Background:

Mucopolysaccharides (also known as glycosaminoglycans (GAGs)) are excreted in excessive amount and in unusual patterns in several lysosomal storage disorders involving mucopolysaccharide metabolism such as Hurler, Hunter, Sanfillipo, Morquio, or Maroteaux-Lamy syndromes. Individuals with these disorders may present with skeletal abnormalities, short stature, coarse facial features, hirsutism, corneal clouding, deafness, cardiac valve disease, hepatosplenomegaly, umbilical and inguinal hernias, developmental regression, and behavioral disturbances. This assay combines quantitative measurement of urinary mucopolysaccharide excretion and qualitative analysis of the types of mucopolysaccharides excreted to determine the most likely lysosomal storage disease in a patient.

Methodology:

  • Colorimetric – quantitative urine mucopolysaccharides
  • Gel electrophoresis – qualitative analysis of urine mucopolysaccharides including chondroitin sulfate, dermatan sulfate, heparan sulfate, and keratan sulfate.
  • Creatinine is run concurrently and used to normalize results.

Specimen Requirements:

Urine: 3-5 mL, clean catch spot specimen or aliquot from a timed urine specimen

A REQUISITION FORM MUST ACCOMPANY ALL SAMPLES.  Please include detailed clinical information,  including ethnicity, clinical history, and family history.

Test Performed (Days):

Every Two Weeks

Turn Around Time:

5-14 days

Shipment Sensitivity Requirements:

  • Freeze specimen, package in styrofoam shipper with ample dry ice to keep frozen. 
  • Ship via overnight express, using the FedEx priority overnight label provided. 
  • Contact Client Services at (855) 535-1522 for shipping kits and instructions.

References:

Additional Info:

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More